title: Response to Letter to the Editor on "Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?".
authors.affiliation: Department of Cell Biology and Molecular Medicine, Rutgers, New Jersey Medical School, Newark, New Jersey.
authors.forename: Claudio A
authors.initials: CA
authors.lastname: Bravo
authors.affiliation: Department of Cell Biology and Molecular Medicine, Rutgers, New Jersey Medical School, Newark, New Jersey.
authors.forename: Dorothy E
authors.initials: DE
authors.lastname: Vatner
authors.affiliation: Department of Cell Biology and Molecular Medicine, Rutgers, New Jersey Medical School, Newark, New Jersey vatnersf@njms.rutgers.edu.
authors.forename: Stephen F
authors.initials: SF
authors.lastname: Vatner
mesh_terms: D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases; D006801:Humans; D014740:Vidarabine
chemical_list: D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases; D014740:Vidarabine